In this report, we compare key metrics between Aphria and Canopy Growth, two of the largest licensed Canadian marijuana producers. Our fiscal 2019 EBITDA estimate for both companies are dozens of millions of dollars below the lowest sell-side estimate. In our discussions with those in the industry and analysis of the market, we believe our estimates will end up being closer to actual reported figures. We believe Aphria’s share price will increase (or decrease less) versus Canopy’s beginning from July 14th 2017 to the average last ten trading days closing price in October of 2019. The stock call is good […]